Entropy Technologies LP acquired a new stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 30,246 shares of the technology company’s stock, valued at approximately $6,752,000.
Other hedge funds also recently bought and sold shares of the company. Raiffeisen Bank International AG acquired a new stake in Veeva Systems in the 3rd quarter valued at about $28,000. Board of the Pension Protection Fund purchased a new stake in shares of Veeva Systems in the 4th quarter valued at approximately $27,000. Newbridge Financial Services Group Inc. grew its stake in shares of Veeva Systems by 322.6% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock valued at $29,000 after buying an additional 100 shares during the period. Activest Wealth Management grew its stake in shares of Veeva Systems by 3,175.0% in the 4th quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock valued at $29,000 after buying an additional 127 shares during the period. Finally, BOK Financial Private Wealth Inc. purchased a new stake in shares of Veeva Systems in the 4th quarter valued at approximately $33,000. Institutional investors and hedge funds own 88.20% of the company’s stock.
Veeva Systems Stock Performance
NYSE:VEEV opened at $159.44 on Friday. The stock has a market capitalization of $25.90 billion, a P/E ratio of 28.42, a PEG ratio of 0.69 and a beta of 0.95. The company has a 50 day moving average price of $165.06 and a 200 day moving average price of $192.11. Veeva Systems Inc. has a fifty-two week low of $148.05 and a fifty-two week high of $310.50.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on VEEV shares. Mizuho dropped their price target on shares of Veeva Systems from $295.00 to $270.00 and set an “outperform” rating for the company in a research note on Thursday, June 4th. Citigroup increased their price target on shares of Veeva Systems from $176.00 to $190.00 and gave the company a “neutral” rating in a research note on Thursday, June 4th. TD Cowen reissued a “buy” rating on shares of Veeva Systems in a research note on Thursday, June 4th. Oppenheimer reissued an “outperform” rating and issued a $225.00 price target on shares of Veeva Systems in a research note on Thursday, June 4th. Finally, Piper Sandler dropped their price target on shares of Veeva Systems from $285.00 to $235.00 and set an “overweight” rating for the company in a research note on Thursday, June 4th. Eighteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $250.96.
Check Out Our Latest Stock Analysis on VEEV
Insider Buying and Selling at Veeva Systems
In related news, Director Priscilla Hung sold 750 shares of the stock in a transaction that occurred on Thursday, April 30th. The shares were sold at an average price of $155.64, for a total transaction of $116,730.00. Following the completion of the transaction, the director owned 3,253 shares of the company’s stock, valued at approximately $506,296.92. This trade represents a 18.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 10.60% of the company’s stock.
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Articles
- Five stocks we like better than Veeva Systems
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
